Please login to the form below

Not currently logged in
Email:
Password:

Roche reveals new vice-president of commercial operations

Roche hires Steven C Sembler as its new vice-president of US commercial operations for Swiss-headquartered pharmaceutical company, Roche

Roche has hired Steven C Sembler as its new vice-president of US commercial operations for Swiss-headquartered pharmaceutical company, Roche.

Sembler will oversee US marketing and sales for products in a number of key therapeutic areas including oncology, HIV, hepatitis and anti-infectives. He will also become a member of the Roche's senior management team and will report to president and CEO, George Abercrombie. Sembler's appointment was effective from 1 January 2008. He replaced Gary Zieziula, who was named the new general manager of Roche in Greece.

Previously, Sembler was vice-president of oncology for the US pharmaceuticals organisation and was responsible for all aspects of Roche's US-based oncology business. He has over 25 years of experience in the pharmaceutical industry and has been involved in oncology since 1985.

Before joining Roche in 2004, Sembler was employed by UK-headquartered GlaxoSmithKline (GSK), US-based BMS and the Purdue Frederick Company, where he held positions in sales management, marketing, new product development and lifecycle management.

Throughout his career, Sembler has also been a strong supporter, advisor and key advocate of numerous oncology patient advocacy organisations and developed a passion for ensuring patient access to innovative therapies.

14th January 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics